PMC:7275137 / 17378-17728
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T49 | 166-174 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T106 | 120-121 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T107 | 235-236 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T121 | 77-91 | Chemical | denotes | clarithromycin | http://purl.obolibrary.org/obo/CHEBI_3732 |
T122 | 96-108 | Chemical | denotes | erythromycin | http://purl.obolibrary.org/obo/CHEBI_42355|http://purl.obolibrary.org/obo/CHEBI_48923 |
T124 | 129-138 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T125 | 190-200 | Chemical | denotes | macrolides | http://purl.obolibrary.org/obo/CHEBI_25106 |
T126 | 310-320 | Chemical | denotes | macrolides | http://purl.obolibrary.org/obo/CHEBI_25106 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T87 | 0-350 | Sentence | denotes | Considering everything mentioned above and the recent in-silico finding that clarithromycin and erythromycin could have a direct antiviral effect by interfering with COVID-19 protease [38], macrolides should be investigated further as a treatment option, including the route of administration, with inhalatory macrolides being of particular interest. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
294 | 77-91 | Chemical | denotes | clarithromycin | MESH:D017291 |
295 | 96-108 | Chemical | denotes | erythromycin | MESH:D004917 |
296 | 190-200 | Chemical | denotes | macrolides | MESH:D018942 |
297 | 310-320 | Chemical | denotes | macrolides | MESH:D018942 |
307 | 166-174 | Disease | denotes | COVID-19 | MESH:C000657245 |